These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8737372)

  • 1. Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580.
    DaSilva L; Rui H; Erwin RA; Howard OM; Kirken RA; Malabarba MG; Hackett RH; Larner AC; Farrar WL
    Mol Cell Endocrinol; 1996 Mar; 117(2):131-40. PubMed ID: 8737372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
    Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
    Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription.
    Han Y; Watling D; Rogers NC; Stark GR
    Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
    Jabbour HN; Critchley HO; Boddy SC
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.
    Pezet A; Ferrag F; Kelly PA; Edery M
    J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple prolactin (PRL) receptor cytoplasmic residues and Stat1 mediate PRL signaling to the interferon regulatory factor-1 promoter.
    Wang Y; O'Neal KD; Yu-Lee L
    Mol Endocrinol; 1997 Aug; 11(9):1353-64. PubMed ID: 9259325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
    Ali S; Ali S
    J Biol Chem; 1998 Mar; 273(13):7709-16. PubMed ID: 9516478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
    Russell DL; Richards JS
    Mol Endocrinol; 1999 Dec; 13(12):2049-64. PubMed ID: 10598581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
    Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
    J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective coupling of STAT factors to the mouse prolactin receptor.
    Mayr S; Welte T; Windegger M; Lechner J; May P; Heinrich PC; Horn F; Doppler W
    Eur J Biochem; 1998 Dec; 258(2):784-93. PubMed ID: 9874248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid.
    Rui H; Xu J; Mehta S; Fang H; Williams J; Dong F; Grimley PM
    J Biol Chem; 1998 Jan; 273(1):28-32. PubMed ID: 9417042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells.
    Pallard C; Gouilleux F; Charon M; Groner B; Gisselbrecht S; Dusanter-Fourt I
    J Biol Chem; 1995 Jul; 270(27):15942-5. PubMed ID: 7608147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
    Wagner KU; Krempler A; Triplett AA; Qi Y; George NM; Zhu J; Rui H
    Mol Cell Biol; 2004 Jun; 24(12):5510-20. PubMed ID: 15169911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F; Chiarenza A; Goffin V; Kelly PA
    Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes.
    Dogusan Z; Hooghe R; Verdood P; Hooghe-Peters EL
    J Neuroimmunol; 2001 Nov; 120(1-2):58-66. PubMed ID: 11694320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
    McWhinney CD; Dostal D; Baker K
    J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor.
    Pezet A; Buteau H; Kelly PA; Edery M
    Mol Cell Endocrinol; 1997 May; 129(2):199-208. PubMed ID: 9202403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.